8-K: LivePerson Appoints Ryan Vardeman to Board

LivePerson, Inc. announced the appointment of Ryan L. Vardeman, a principal of Palogic Value Management, to its Board of Directors, effective October 14, 2025.

Summary

• LivePerson, Inc. appointed Ryan L. Vardeman as a Class III director to its Board of Directors, with his term expiring at the Company's 2027 Annual Meeting of Stockholders.
• Mr. Vardeman's nomination was made pursuant to the Exchange Agreement dated August 11, 2025, with certain former holders of the Company's 0% Senior Convertible Notes due 2026.
• Mr. Vardeman is a principal and co-founder of Palogic Value Management, L.P., an investment management company, and brings extensive experience in corporate strategy, finance, and investment, particularly in technology and software.
• Palogic Value Fund, LP, whose general partner is Palogic Value Management LP, participated in the Exchange Agreement, receiving approximately $1.3 million in cash, $3.3 million principal amount of Second Lien Senior Subordinated Secured Notes due 2029, 106,198 post-reverse-split common shares, and 762 shares of Series B Preferred Stock.
• The Company issued a press release on October 20, 2025, announcing the appointment.

Sentiment

Score: 7

Explanation: The appointment of an experienced director with a strong financial and technology background is generally positive for corporate governance and strategic execution. The related party transaction, while significant, is a consequence of a previously announced agreement, indicating progress in restructuring.

Positives

• Appointment of Ryan L. Vardeman, an experienced professional with a strong background in finance, corporate strategy, and investment management, particularly in technology and software companies.
• Mr. Vardeman's expertise is expected to be an asset in executing the Company's strategy and delivering shareholder value.
• The appointment stems from a previously announced Exchange Agreement, indicating a structured approach to board composition and resolution of prior financial arrangements.

Risks

• Forward-looking statements are subject to risks and uncertainties, and actual events or results may differ materially from expectations.
• Factors that could cause differences include the Company's ability to execute on and deliver its current business, sales, go-to-market, and product plans and goals.
• Other factors described in the 'Risk Factors' sections of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, and Quarterly Reports on Form 10-Q, including for the quarter ended June 30, 2025.

Future Outlook

The Company aims to continue executing its strategy with a focus on delivering value for shareholders and customers, leveraging its leadership in conversational AI and digital transformation. Forward-looking statements are subject to risks related to the Company's ability to execute its business, sales, go-to-market, and product plans.

Management Comments

• "We are delighted to welcome Ryan to the LivePerson Board. His strong track record in finance, operations, and corporate strategy in the software industry will be an asset as the Company continues to execute its strategy with a focus on delivering value for shareholders and customers." Jim Miller, Board Chair.
• "LivePerson has been a longstanding leader in the space of conversational AI, with a strong vision for the future of business-to-consumer engagement. I am excited about the opportunity to work with the board and management team to achieve the company's objectives and build enhanced value for shareholders." Ryan Vardeman.

Industry Context

LivePerson operates in the rapidly evolving conversational AI and digital transformation space. The appointment of a director with extensive experience in technology and software investment management, particularly with a focus on small-cap equities and capital structure analysis, suggests a strategic move to enhance financial oversight and strategic execution within a competitive and innovation-driven industry. The company positions itself as a leader in enterprise conversational AI, powering nearly a billion conversational interactions monthly.

Management Changes

Corporate Governance

Related Party Transactions

• Palogic Value Fund, LP, whose general partner is Palogic Value Management LP (where newly appointed director Ryan L. Vardeman is a principal), participated as a Noteholder in the Exchange Agreement.
• As consideration for exchanging its 0% Senior Convertible Notes due 2026, Palogic Value Fund, LP received approximately $1.3 million in cash, approximately $3.3 million principal amount of Second Lien Senior Subordinated Secured Notes due 2029, 106,198 shares of common stock (post-reverse-split), and 762 shares of Series B Fixed Rate Convertible Perpetual Preferred Stock.

Stakeholder Impact

• Shareholders: The appointment of an experienced director could enhance strategic decision-making and corporate governance, potentially leading to improved shareholder value. The details of the Exchange Agreement, involving a significant noteholder, impact the capital structure and ownership.
• Noteholders (former 2026 Notes): Those who participated in the Exchange Agreement, like Palogic Value Fund, received a combination of cash, new notes, and equity, altering their investment profile in the Company.
• Employees/Customers: Indirect positive impact from potentially stronger strategic direction and financial health.

Next Steps

• Any committee appointments for Mr. Vardeman will be subsequently disclosed.
• The Company intends to enter into its form of director and executive officer indemnification agreement with Mr. Vardeman.
• The Company will continue to execute its strategy with a focus on delivering value for shareholders and customers.

Key Dates

Recommendation

The appointment of a director with strong financial and technology experience is a positive governance step, and the related party transaction clarifies the outcome of a prior exchange agreement. However, without broader financial results or strategic updates beyond this specific event, a 'hold' recommendation is prudent. The filing doesn't provide enough information to warrant a 'buy' or 'sell' based solely on this director appointment and the details of a past note exchange, though it does signal a potentially more engaged investor on the board. The company's overall financial health and future prospects, as detailed in its 10-K and 10-Q, would be crucial for a stronger recommendation.

Keywords

LivePerson, LPSN, Board of Directors, Director Appointment, Corporate Governance, Ryan Vardeman, Palogic Value Management, Exchange Agreement, Convertible Notes, Technology, Conversational AI, Software